Table 4.

Clinical impact of risk score signature for the CCGA cohort

Clinicopathological feature	n	Risk score
		Mean	SD	t	P
Grade
I–II	216	1.203847424	0.8808	10.898	< 0.001
III–IV	109	0.245607385	0.6717
Radiotherapy
Yes	212	0.777059137	0.9674	−2.267	0.025
No	84	1.029456602	0.8189
Chemotherapy
Yes	158	1.01284085	0.8665	2.604	0.01
No	128	0.727299406	0.9862
IDH (DNA and RNA)
Mutation	171	0.497626264	0.8174	−8.69	< 0.001
Wildtype	154	1.30979323	0.8671
IDH1‐R32
Wildtype	162	0.509472199	0.8242	−7.824	< 0.001
Mutation	163	1.253176395	0.8881
TP53.1
Wildtype	189	0.937494898	0.9505	1.254	0.211
Mutation	136	0.805997888	0.9062
EGFR
Wildtype	110	0.770831973	0.9802	−1.546	0.123
Mutation	215	0.939584798	0.905
ATRX
Wildtype	33	0.856142312	0.9358	−0.171	0.865
Mutation	292	0.885443672	0.9343
EZH2
Wildtype	37	1.182088779	1.1162	1.77	0.084
Mutation	288	0.843975569	0.9019